Literature DB >> 8225455

Clinical study of 100 cases of Kyasanur Forest disease with clinicopathological correlation.

M R Adhikari Prabha1, M G Prabhu, C V Raghuveer, M Bai, M A Mala.   

Abstract

100 cases of Kyasanur Forest Disease were studied clinically and autopsy or postmortem biopsies of various organs were done in 8 cases. 1. Our study showed that KFD passes through 4 stages each lasting for about a week. i.e. a prodromal stage with fever, hypotension hepatomegaly, a stage of complication characterized by haemorrhage, neurological manifestation or bronchopneumonia, a stage of recovery followed by a li stage of fever in some cases. 2. The exact of cause of haemorrhage could not be identified though Disseminated Intravascular Coagulation was suspected. 3. Hypotension in KFD could be of Myocardial origin. 4. Encephalopathy in KFD could be due to a metabolic cause probably of hepatic origin. 5. Lung signs could be due to intraalveolar haemorrhage and secondary infection.

Entities:  

Mesh:

Year:  1993        PMID: 8225455

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  12 in total

Review 1.  The ecology of emerging neurotropic viruses.

Authors:  Kevin J Olival; Peter Daszak
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

Review 2.  Emergence of the severe syndrome and mortality associated with dengue and dengue-like illness: historical records (1890 to 1950) and their compatibility with current hypotheses on the shift of disease manifestation.

Authors:  Goro Kuno
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 3.  Kyasanur forest disease.

Authors:  Michael R Holbrook
Journal:  Antiviral Res       Date:  2012-10-27       Impact factor: 5.970

4.  Kyasanur Forest disease virus infection in mice is associated with higher morbidity and mortality than infection with the closely related Alkhurma hemorrhagic fever virus.

Authors:  Kimberly A Dodd; Brian H Bird; Megan E B Jones; Stuart T Nichol; Christina F Spiropoulou
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

5.  Clinical and Laboratory Diagnostic Features of Kyasanur Forest Disease: A Study From Wayanad, South India.

Authors:  Vineeth Gladson; Hisham Moosan; Sheela Mathew; Dineesh P
Journal:  Cureus       Date:  2021-12-06

6.  Kyasanur forest disease virus: viremia and challenge studies in monkeys with evidence of cross-protection by Langat virus infection.

Authors:  Keerti V Shah; Chandu N Dandawate; Pravin N Bhatt
Journal:  F1000Res       Date:  2012-12-07

Review 7.  Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.

Authors:  Syed Z Shah; Basit Jabbar; Nadeem Ahmed; Anum Rehman; Hira Nasir; Sarooj Nadeem; Iqra Jabbar; Zia Ur Rahman; Shafiq Azam
Journal:  Front Cell Infect Microbiol       Date:  2018-05-09       Impact factor: 5.293

8.  Kyasanur Forest disease virus non-mouse animal models: a pilot study.

Authors:  A M Nikiforuk; K Tierny; T A Cutts; D K Kobasa; S S Theriault; B W M Cook
Journal:  BMC Res Notes       Date:  2020-06-15

Review 9.  Clinical & epidemiological significance of Kyasanur forest disease.

Authors:  Ashok Munivenkatappa; Rima Rakesh Sahay; Pragya D Yadav; Rajalakshmi Viswanathan; Devendra T Mourya
Journal:  Indian J Med Res       Date:  2018-08       Impact factor: 2.375

Review 10.  Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus-Two Neglected Zoonotic Pathogens.

Authors:  Bharti Bhatia; Heinz Feldmann; Andrea Marzi
Journal:  Microorganisms       Date:  2020-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.